[Form 4] SANUWAVE Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Community Healthcare Trust Inc. (CHCT) filed a Form 4 disclosing that its Executive Vice President & Chief Financial Officer, William G. Monroe IV, had a single reportable transaction on 30 June 2025.

• Transaction code F indicates shares were withheld to satisfy tax obligations associated with equity compensation.
• 650 shares of common stock were disposed of at an average price of $16.77 per share.
• Following the transaction, Monroe directly owns 149,759 CHCT common shares.
• No derivative securities were acquired or disposed of, and no other transactions were reported.

The filing was signed on 2 July 2025 by attorney-in-fact Nathanael P. Kibler.

Insights

Securities Analyst

TL;DR — Minor routine tax-withholding sale; neutral impact.

The sole transaction involves 650 shares, valued at roughly $11 K, representing less than 0.5 % of Mr. Monroe’s post-transaction holdings. The F code denotes a tax-related disposition rather than an open-market sale, limiting any signaling effect about management’s outlook. His substantial remaining stake of 149,759 shares suggests continued alignment with shareholders. Given the small size and routine nature, I view the filing as non-material for valuation or sentiment purposes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Ian D.

(Last) (First) (Middle)

11495 VALLEY VIEW ROAD

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$32.86	06/30/2025		A		1,771		(1)	06/30/2030	Common Stock	1,771	$0	1,771	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for Ian D. Miller	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CHCT report on Form 4?

The CFO had 650 CHCT shares withheld for taxes on 30-Jun-2025 at $16.77 each.

How many CHCT shares does the CFO own after the transaction?

William G. Monroe IV directly owns 149,759 common shares after the filing.

Was the CHCT insider sale an open-market transaction?

No. Code F shows shares were withheld to cover tax liabilities, not sold on the open market.

Did the filing report any derivative securities activity for CHCT?

No derivative securities were acquired or disposed of in this Form 4.

When was the Form 4 for CHCT filed?

The document was signed and filed on 2 July 2025.